# Nektar Therapeutics: filings

NKTR · Nasdaq · CIK 906709 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nktr.md) · [Financials](/companies/nktr/financials.md) · [Filings](/companies/nktr/filings.md) · [Insiders](/companies/nktr/insiders.md)

## Reports and events: 341 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 673, 8-K 249, SC 13G/A 95, 144 54, 10-Q 53, 4/A 26, 10-K 18, 3 18, DEF 14A 18, SC 13G 18, SCHEDULE 13G/A 17, DEFA14A 15, S-8 15, 424B5 13, UPLOAD 13, CORRESP 11, SCHEDULE 13G 10, CT ORDER 9, 5 6, S-3ASR 4, ARS 3, 8-K/A 2, D 2, EFFECT 2, S-3 2, 10-K/A 1, 424B3 1, DRS 1, DRSLTR 1, PRE 14A 1, SD 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 11:57 ET | [8-K](/filings/0001213900-26-105453.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-105453 |
| 2026-09-25 | 11:00 ET | [8-K](/filings/0001213900-26-103215.md) | 8.01 Other events | 0001213900-26-103215 |
| 2026-09-08 | 20:10 ET | [8-K](/filings/0001213900-26-098042.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-098042 |
| 2026-08-14 | 22:57 ET | [10-Q](/filings/0001193125-26-349805.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349805 |
| 2026-08-13 | 20:25 ET | [8-K](/filings/0001213900-26-089137.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-089137 |
| 2026-06-05 | 20:30 ET | [8-K](/filings/0001213900-26-065845.md) | 5.07 Shareholder vote results | 0001213900-26-065845 |
| 2026-05-08 | 21:11 ET | [8-K](/filings/0001193125-26-214976.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-214976 |
| 2026-05-08 | 22:20 ET | [10-Q](/filings/0001193125-26-212596.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212596 |
| 2026-05-07 | 20:30 ET | [8-K](/filings/0001213900-26-053369.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-053369 |
| 2026-04-24 | 20:15 ET | [DEF 14A](/filings/0001140361-26-016708.md) | Proxy statement, period 2026-06-04 | 0001140361-26-016708 |
| 2026-04-23 | 10:06 ET | [8-K](/filings/0001193125-26-171731.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-171731 |
| 2026-04-20 | 20:58 ET | [8-K](/filings/0001193125-26-164186.md) | 7.01 Regulation FD disclosure | 0001193125-26-164186 |
| 2026-04-20 | 12:02 ET | [8-K](/filings/0001193125-26-162763.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-162763 |
| 2026-03-13 | 22:12 ET | [10-K](/filings/0001193125-26-104547.md) | Annual report, period 2025-12-31 | 0001193125-26-104547 |
| 2026-03-12 | 20:45 ET | [8-K](/filings/0001213900-26-027026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-027026 |
| 2026-02-13 | 01:23 ET | [8-K](/filings/0001193125-26-049378.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-049378 |
| 2026-02-10 | 21:21 ET | [8-K](/filings/0001193125-26-044751.md) | 7.01 Regulation FD disclosure | 0001193125-26-044751 |
| 2026-02-10 | 13:05 ET | [8-K](/filings/0001193125-26-043755.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-043755 |
| 2026-01-27 | 21:02 ET | [8-K](/filings/0001213900-26-008210.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-008210 |
| 2025-12-16 | 13:00 ET | [8-K](/filings/0001193125-25-320009.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-320009 |
| 2025-11-21 | 21:06 ET | [8-K](/filings/0001213900-25-113606.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-113606 |
| 2025-11-10 | 11:31 ET | [8-K](/filings/0001213900-25-107821.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-107821 |
| 2025-11-07 | 22:58 ET | [10-Q](/filings/0001193125-25-270230.md) | Quarterly report, period 2025-09-30 | 0001193125-25-270230 |
| 2025-11-06 | 21:24 ET | [8-K](/filings/0001213900-25-107180.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-107180 |
| 2025-09-18 | 12:56 ET | [8-K](/filings/0001213900-25-088792.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-088792 |
| 2025-08-08 | 21:59 ET | [10-Q](/filings/0000950170-25-105275.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105275 |
| 2025-08-07 | 20:26 ET | [8-K](/filings/0001213900-25-073100.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-073100 |
| 2025-07-01 | 20:44 ET | [8-K](/filings/0001193125-25-154062.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-154062 |
| 2025-06-27 | 21:15 ET | [8-K](/filings/0001213900-25-059115.md) | 8.01 Other events | 0001213900-25-059115 |
| 2025-06-24 | 11:45 ET | [8-K](/filings/0001213900-25-056909.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-056909 |
| 2025-06-06 | 20:30 ET | [8-K](/filings/0001213900-25-052141.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-052141 |
| 2025-06-04 | 20:30 ET | [8-K](/filings/0001213900-25-051191.md) | 8.01 Other events | 0001213900-25-051191 |
| 2025-05-28 | 22:27 ET | [8-K](/filings/0001213900-25-047890.md) | 5.07 Shareholder vote results | 0001213900-25-047890 |
| 2025-05-09 | 22:01 ET | [10-Q](/filings/0000950170-25-067279.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067279 |
| 2025-05-08 | 20:20 ET | [8-K](/filings/0001213900-25-041085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-041085 |
| 2025-04-25 | 20:15 ET | [DEF 14A](/filings/0001140361-25-015744.md) | Proxy statement, period 2025-05-23 | 0001140361-25-015744 |
| 2025-04-04 | 20:05 ET | [8-K](/filings/0001213900-25-029002.md) | 3.01 Delisting notice | 0001213900-25-029002 |
| 2025-03-28 | 21:09 ET | [8-K](/filings/0001013762-25-004236.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001013762-25-004236 |
| 2025-03-14 | 20:02 ET | [10-K](/filings/0000950170-25-039389.md) | Annual report, period 2024-12-31 | 0000950170-25-039389 |
| 2025-03-12 | 20:20 ET | [8-K](/filings/0001213900-25-023220.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-023220 |
| 2025-02-24 | 12:10 ET | [8-K](/filings/0001213900-25-016278.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-016278 |
| 2025-02-04 | 21:15 ET | [8-K](/filings/0001213900-25-010085.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010085 |
| 2024-12-02 | 14:24 ET | [8-K](/filings/0001213900-24-104240.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001213900-24-104240 |
| 2024-11-08 | 22:59 ET | [10-Q](/filings/0000950170-24-123570.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123570 |
| 2024-11-07 | 21:31 ET | [8-K](/filings/0001213900-24-095423.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-095423 |
| 2024-11-04 | 13:52 ET | [8-K](/filings/0001213900-24-093768.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-093768 |
| 2024-08-09 | 21:51 ET | [10-Q](/filings/0000950170-24-094231.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094231 |
| 2024-08-08 | 20:20 ET | [8-K](/filings/0001213900-24-066630.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-066630 |
| 2024-06-06 | 20:05 ET | [8-K](/filings/0001213900-24-050365.md) | 5.07 Shareholder vote results | 0001213900-24-050365 |
| 2024-05-10 | 22:00 ET | [10-Q](/filings/0000950170-24-057312.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057312 |

Page 1 of 7. [Older](/companies/nktr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.